BRIEF published on 09/24/2026 at 17:13, 1 month 11 days ago Marinomed Biotech AG cesse ses activités suite à une décision d'insolvabilité Marinomed Biotech AG Restructuration Insolvabilité Vente D'actifs Unither Pharmaceuticals
BRIEF published on 09/24/2026 at 17:13, 1 month 11 days ago Marinomed Biotech AG Ceases Operations Following Insolvency Ruling Restructuring Asset Sale Insolvency Marinomed Biotech AG Unither Pharmaceuticals
PRESS RELEASE published on 09/24/2026 at 17:08, 1 month 11 days ago Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): n.a. First Berlin Equity Research ends coverage of Marinomed Biotech AG after company's decision to close operations. Insolvency administrator to initiate sale of assets First Berlin Equity Research Asset Sale Insolvency Marinomed Biotech AG Coverage End
BRIEF published on 09/24/2026 at 10:42, 1 month 11 days ago Marinomed Biotech AG annonce sa fermeture suite à une insolvabilité Marinomed Biotech AG Insolvabilité Vente D'actifs Négociations Avec Les Investisseurs Fermeture De L'entreprise
BRIEF published on 09/24/2026 at 10:42, 1 month 11 days ago Marinomed Biotech AG Announces Closure Following Insolvency Asset Sale Insolvency Investor Negotiations Marinomed Biotech AG Company Closure
PRESS RELEASE published on 09/24/2026 at 10:37, 1 month 11 days ago EQS-Adhoc: Cessation of operations and closure of the company Marinomed Biotech AG announces cessation of operations and closure of the company due to unsuccessful business results, uncompleted sale of licensing rights, and unsuccessful investor discussions Insolvency Marinomed Biotech AG Closure Cessation Of Operations Investor Discussions
BRIEF published on 07/22/2026 at 14:53, 3 months 14 days ago Marinomed Biotech entame une restructuration sans autogestion Marinomed Biotech AG Unither Pharmaceuticals Liquidité Des Parts Procédures De Restructuration Instabilité Financière
BRIEF published on 07/22/2026 at 14:53, 3 months 14 days ago Marinomed Biotech Initiates Restructuring Without Self-Administration Marinomed Biotech AG Share Liquidity Restructuring Proceedings Unither Pharmaceuticals Financial Instability
BRIEF published on 07/22/2026 at 14:48, 3 months 14 days ago Marinomed Biotech AG demande une restructuration judiciaire face aux difficultés du marché Marinomed Biotech AG Liquidité Du Marché Banque Raiffeisen Restructuration Judiciaire Plateforme Marinosolv®
BRIEF published on 07/22/2026 at 14:48, 3 months 14 days ago Marinomed Biotech AG Seeks Court Restructuring amid Market Challenges Marinomed Biotech AG Market Liquidity Raiffeisen Bank Marinosolv® Platform Court Restructuring
Published on 11/06/2026 at 05:15, 2 hours 57 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 7 hours 19 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 7 hours 27 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 8 hours 17 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/06/2026 at 08:00, 12 minutes ago Gledhow Investments plc: Strategic Update: Originating the Next Generation of Listed Natural Resources Companies; Issue of Equity and Repayment of all outstanding Debt
Published on 11/06/2026 at 08:00, 12 minutes ago Schweizer Electronic AG continues on its growth trajectory and achieves a turnaround in earnings in the third quarter
Published on 11/06/2026 at 07:30, 42 minutes ago Baader Bank launches Baader Trading Charity Weeks in support of BILD hilft e.V. „Ein Herz für Kinder“
Published on 11/06/2026 at 07:00, 1 hour 12 minutes ago ARYZTA announces upcoming departure of its CFO
Published on 11/05/2026 at 18:21, 13 hours 50 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 13 hours 50 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
